On Wednesday, the World Well being Group (WHO) authorized the first-ever vaccine for the prevention of malaria. Officers with the group referred to as it a “glimmer of hope” for Africa.
The WHO advice is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline.
Since 2019, 2.3 million doses of Mosquirix have been administered to infants in Ghana, Kenya and Malawi as a part of a large-scale pilot program coordinated by the well being company.
Malaria killed roughly 386,000 Africans in 2019, in line with a WHO estimate. The vast majority of these killed by the illness have been kids.
Malaria is brought on by parasites transmitted by means of the chew of an contaminated mosquito.
For more information, please go to
Subscribe to International Information Channel HERE:
Like International Information on Fb HERE:
Comply with International Information on Twitter HERE:
Comply with International Information on Instagram HERE:
#Mosquirix #Well being #malaria #GlobalNews
source